ZO(BQ.5@7A,@7%Y426MP(&&FAOI#<+
SYSTEM PROCESSING...
ZO(BQ.5@7A,@7%Y426MP(&&FAOI#<+
SYSTEM PROCESSING...
Posted: 2025-07-08 13:06:21 UTC

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-07-08 13:06:37 UTC
Verified By
Rollup News
Neural stem cell grafts have shown the ability to restore myelin in damaged regions of the central nervous system, offering a potential breakthrough for treating progressive multiple sclerosis (MS). The research indicates that these stem cells can mature into oligodendrocytes, which are responsible for producing myelin, and integrate safely into MS-like lesions in mice, paving the way for clinical trials exploring stem cell-based treatments.
Remyelination of damaged nerves
Potential treatment for progressive MS
Development of patient-centered therapies